CIMZIA
CIMZIA (certolizumab pegol) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells, helping to protect healthy cells from damage. Specifically, it is a tumor necrosis factor blocker (TNF) for treatment of Crohn’s disease, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
What it treats
Rheumatoid Arthritis,
Psoriatic Arthritis,
Ankylosing Spondylitis,
Crohn’s Disease,
Plaque Psoriasis,
Non-Radiographic Axial Spondyloarthritis
Prescribed by
Rheumatologists, Gastroenterologists & Dermatologists
How it’s administered
Subcutaneous injection
Frequency
Initial dose, then two weeks later, then four
weeks later, and lastly every four weeks after
Length of treatment
About 15 minutes